Action Observation Therapy in Patients Undetgoing Surgery for Shoulder Instability
Effects of Action Observation Therapy in Patients Undergoing Surgery for Shoulder-instability
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Study Type
Study Type
Enrollment (Anticipated)
Enrollment
Phase
Phase
- Not Applicable
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Subjects undergoing capsule-plastic surgery or Latarjet stabilization for shoulder instability
Exclusion Criteria:
- Previous upper limb surgery
- Cognitive impairments
- Visual or auditory impairments
- Postoperative complications limiting upper limb motor recovery (e.g., infections)
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Number of Arms
Arms and Interventions
Participant Group / ArmParticipant Group / Arm |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
No Intervention: Control
|
|
|
Experimental: AOT
|
Participants will watch 12-minute video-clips followed by 8 minutes of motor imagery.
Video-clips observation and imagination will be focused un shoulder tasks occuring on the three planes of motion.
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Changes in shoulder function
Time Frame: At baseline, after 4 weeks of training and at 3 month after the training end
|
Simple shoulder test
|
At baseline, after 4 weeks of training and at 3 month after the training end
|
|
Changes in shoulder function
Time Frame: At baseline, after 4 weeks of training and at 3 month after the training end
|
Disability Arm Shoulder Hand - DASH
|
At baseline, after 4 weeks of training and at 3 month after the training end
|
Secondary Outcome Measures
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Changes in shoulder pain
Time Frame: At baseline, after 4 weeks of training and at 3 month after the training end
|
Numerical Pain Rating Scale (0 - best outcome, 100 worst outcome)
|
At baseline, after 4 weeks of training and at 3 month after the training end
|
|
Changes in shoulder range of motion
Time Frame: At baseline, after 4 weeks of training and at 3 month after the training end
|
Flexion, abduction, inernal and external rotation range of motion assessed using a goniometer
|
At baseline, after 4 weeks of training and at 3 month after the training end
|
|
Changes in fear of movement
Time Frame: At baseline, after 4 weeks of training and at 3 month after the training end
|
Tampa scale of kinesiophobia
|
At baseline, after 4 weeks of training and at 3 month after the training end
|
|
Changes in quality of life
Time Frame: At baseline, after 4 weeks of training and at 3 month after the training end
|
Short Form - 36 items
|
At baseline, after 4 weeks of training and at 3 month after the training end
|
Collaborators and Investigators
Sponsor
Sponsor
Study record dates
Study Major Dates
Study Start (Anticipated)
Study Start
Primary Completion (Anticipated)
Primary Completion
Study Completion (Anticipated)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Actual)
First Posted
Study Record Updates
Last Update Posted (Actual)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
Other Study ID Numbers
- CLF21/03
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.